Inobrodib

Study to Evaluate CCS1477 (inobrodib) in Haematological Malignancies

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1/2
Enrollment
250 patients (estimated)
Sponsors
CellCentric Ltd.
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1718
NCT Identifier
NCT04068597

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.